Carrie Jones, ND, MPH - LDN and Cellular Hypothyroidism: Why you can't convert T4 into T3 (2019 Conference) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr. Brian Udell, Low Dose Naltrexone - Key Ingredient in the biomedical treatment of Autism Spectrum Disorder.

Learn about autism, the epidemic, and how LDN fits into a comprehensive therapeutic protocol to allow healing to take place. 

Elizabeth Livengood, NMD - LDN and MDD: A Case Study - Treating Depression in Patients with Autoimmune Conditions (2019 Conference) (LDN, low dose naltrexone)

Armin Schwarzbach, PhD, MD - Infections in Cancer and Autoimmune Disorders II (2019 Conference) (LDN, low dose naltrexone)

Dr Akbar Khan's LDN 2019 Conference Presentation

Low Dose Naltrexone (LDN) vs. Chemotherapy: One “Unproven” Therapy Against Another?

Yoon Hang "John" Kim, MD - Treating chronic pain with low dose naltrexone and ultra low dose naltrexone (2019 Conference) (LDN, low dose naltrexone)

Ted Cole, DO - The Use of LDN and Amino Acids in Parkinson's Disease (2019 Conference) (LDN, low dose naltrexone)

LDN 2019 Conference - Sunday Q&A (2019 Conference) (LDN, low dose naltrexone)

Presentations on the below and questions were asked in relation to:

Scott Zashin, MD - Treatment of Sjogren's Syndrome with LDN (2019 Conference) (LDN, low dose naltrexone)

LDN 2019 Conference - Saturday Afternoon Q&A (2019 Conference) (LDN, low dose naltrexone)

Presentations on the below and questions were asked in relation to: